Last edition
News about "Jiangsu Vcare Pharmatech"
Vcare, Huadong Medicine Join Forces to Commercialise JAK1 Inhibitor VC005 Tablets in China
Jiangsu Vcare Pharmatech has entered an exclusive strategic partnership with Huadong Medicine to commercialize its innovative JAK1 inhibitor VC005 tablets for autoimmune diseases in China.
Jiangsu Vcare Pharmatech | 16/08/2025 | By Mrinmoy Dey | 439
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members